Strides Shasun Gets USFDA Go-Ahead For Anti-Allergy Drug Business Business / Business 6 years ago 348 Views comments Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million. Read more
Business Sensex falls by 98 points to close at 32,537.41 | सिमित दायरे में बाजार Business / Business - 6 years ago
Business Big Story Big Debate: Will Supreme Court solve the biggest controversy of faith? Business / Business - 6 years ago
Business Relief for EMI defaulters! Banks not to pressurise defaulters for lump sum Business / Business - 6 years ago
Business Beyond Market Investorial: Get answers to all your share market related queries here Business / Business - 6 years ago
Comments